New, Progeria Triple Drug Trial Begins!
Michiel and Amber
The Progeria Research Foundation and Children's Hospital Boston are once again partnering to conduct a second clinical trial for children with Progeria. This exciting and much larger trial will include up to 45 children from 19 countries!
Since the start of the first Progeria drug trial, researchers have identified two drugs that, when used in combination with the current FTI drug being tested, may provide an even more effective treatment for children with Progeria than FTI's alone. So we're not wasting any time - as the first trial is ending, we're moving right into the next!"
No comments:
Post a Comment